SOP for document archiving Switzerland – Clinical Research Made Simple https://www.clinicalstudies.in Trusted Resource for Clinical Trials, Protocols & Progress Sat, 30 Aug 2025 00:38:46 +0000 en-US hourly 1 https://wordpress.org/?v=6.9.1 SOP for Swiss Ethics and BASEC Submissions and Communications https://www.clinicalstudies.in/sop-for-swiss-ethics-and-basec-submissions-and-communications/ Sat, 30 Aug 2025 00:38:46 +0000 https://www.clinicalstudies.in/?p=7143 Read More “SOP for Swiss Ethics and BASEC Submissions and Communications” »

]]>
SOP for Swiss Ethics and BASEC Submissions and Communications

{
“@context”: “https://schema.org”,
“@type”: “Article”,
“mainEntityOfPage”: {
“@type”: “WebPage”,
“@id”: “https://www.clinicalstudies.in/swiss-ethics-and-basec-submissions-and-communications”
},
“@id”: “https://www.clinicalstudies.in/swiss-ethics-and-basec-submissions-and-communications”,
“headline”: “SOP for Swiss Ethics and BASEC Submissions and Communications”,
“name”: “SOP for Swiss Ethics and BASEC Submissions and Communications”,
“description”: “Comprehensive SOP for managing submissions and communications with Swiss Ethics Committees (via BASEC) in compliance with Swissmedic regulations and ICH GCP.”,
“keywords”: “Swiss ethics submission SOP, BASEC submission SOP, SOP for Swiss EC communications, SOP for ethics approval Switzerland, SOP for site-level ethics submissions, SOP for sponsor responsibilities Swiss ethics, SOP for trial governance Switzerland, SOP for clinical trial application Swiss ethics, SOP for EC correspondence management, SOP for investigator EC compliance, SOP for ethics resubmissions Switzerland, SOP for dual submission Swissmedic BASEC, SOP for cultural and linguistic compliance Switzerland, SOP for document archiving Switzerland, SOP for protocol amendments EC Switzerland, SOP for safety reporting EC Switzerland, SOP for ethics committee meeting minutes Switzerland, SOP for sponsor-EC interactions Switzerland, SOP for trial lifecycle ethics Switzerland, SOP for ethics approval tracker, SOP for inspection readiness ethics submissions Switzerland, SOP for communication logs Switzerland, SOP for ethics documentation Switzerland, SOP for sponsor QA Swiss ethics, SOP for site ethics compliance Switzerland”,
“articleSection”: “Standard Operating Procedure”,
“datePublished”: “2025-08-28”,
“dateModified”: “2025-08-28”,
“author”: { “@type”: “Organization”, “name”: “Clinicalstudies.in” },
“publisher”: {
“@type”: “Organization”,
“name”: “Clinicalstudies.in”,
“logo”: { “@type”: “ImageObject”, “url”: “https://www.clinicalstudies.in/logo.png” }
}
}

Swiss Ethics and BASEC Submissions and Communications SOP

Department Clinical Research
SOP No. CS/SWISS-ETHICS/190/2025
Supersedes N.A.
Page No. 1 of 24
Issue Date 28/08/2025
Effective Date 05/09/2025
Review Date 05/09/2027

Purpose

This SOP outlines procedures for preparing, submitting, and managing communications with Swiss Ethics Committees via the Business Administration System for Ethics Committees (BASEC). It ensures compliance with Swissmedic regulations, ICH GCP, and ethical governance requirements in Switzerland.

Scope

This SOP applies to all sponsor-led and investigator-initiated clinical trials conducted in Switzerland requiring submission to Swiss Ethics Committees through BASEC. It covers initial submissions, responses to ethics queries, substantial amendments, safety reporting, communications, and documentation archiving.

Responsibilities

  • Sponsor: Ensures complete and timely ethics submissions through BASEC and maintains oversight of communications.
  • Regulatory Affairs (RA): Prepares submission dossiers, manages BASEC portal entries, and tracks approval status.
  • Principal Investigator (PI): Provides site-specific documentation and ensures compliance with approved protocols.
  • Clinical Project Manager (CPM): Tracks submission timelines and ensures communication logs are maintained.
  • Quality Assurance (QA): Audits ethics submissions and ensures inspection readiness.

Accountability

The Sponsor’s Head of Regulatory Affairs is accountable for ethics submissions and communications. The PI is accountable for ensuring site compliance with approved ethics requirements.

Procedure

1. Preparation of Ethics Submission

  1. Compile submission package including protocol, ICF, IB, recruitment materials, insurance certificate, and investigator CVs.
  2. Translate documents into German, French, or Italian as required by the region.
  3. Maintain Submission Checklist (Annexure-1).

2. Submission through BASEC

  1. Submit the complete application electronically through the BASEC portal.
  2. Record submission reference number and acknowledgment in Submission Log.

3. Ethics Committee Communication

  1. Respond promptly to EC queries through the BASEC portal within defined timelines.
  2. Maintain Communication Log documenting correspondence with ethics committees.

4. Substantial Amendments

  1. Prepare amended documents with tracked changes.
  2. Submit amendments through BASEC prior to implementation.
  3. Record approvals in Amendment Log (Annexure-2).

5. Safety Reporting

  1. Submit SUSARs and DSURs to ECs via BASEC as per timelines.
  2. Ensure acknowledgment receipts are retained in TMF.

6. Documentation and Archiving

  1. Maintain ethics approval letters, submission logs, and correspondence in TMF.
  2. Archive ethics records for at least 10 years or per Swiss retention requirements.

Abbreviations

  • BASEC: Business Administration System for Ethics Committees
  • EC: Ethics Committee
  • Swissmedic: Swiss Agency for Therapeutic Products
  • ICF: Informed Consent Form
  • IB: Investigator’s Brochure
  • CTA: Clinical Trial Application
  • PI: Principal Investigator
  • RA: Regulatory Affairs
  • QA: Quality Assurance
  • CPM: Clinical Project Manager
  • TMF: Trial Master File

Documents

  1. Submission Checklist (Annexure-1)
  2. Amendment Log (Annexure-2)
  3. Communication Log (Annexure-3)

References

Version: 1.0

Approval

Prepared By Checked By Approved By
Name: Rajesh Kumar
Date: 20/08/2025
Signature: __________
Name: Sunita Reddy
Date: 22/08/2025
Signature: __________
Name: Dr. Meera Iyer
Date: 28/08/2025
Signature: __________

Annexures

Annexure-1: Submission Checklist

Document Included (Y/N) Reviewer Date
Protocol Y Rajesh Kumar 05/08/2025
Investigator’s Brochure Y Sunita Reddy 06/08/2025

Annexure-2: Amendment Log

Date Amendment Submitted To Status Owner
15/09/2025 Amendment 1 — Updated ICF BASEC Under Review Neha Sharma

Annexure-3: Communication Log

Date Committee Topic Response Owner
12/08/2025 BASEC Request for clarification on SAE reporting Response provided Sunita Reddy

Revision History

Revision Date Revision No. Revision Details Reason for Revision Approved By
28/08/2025 1.0 Initial SOP for Swiss ethics and BASEC submissions and communications. New SOP created for regulatory compliance in Switzerland. Head of Clinical Research

For more SOPs visit: Pharma SOP.

]]>
SOP for ClinO and ClinO-MD Compliance in Submissions and Conduct https://www.clinicalstudies.in/sop-for-clino-and-clino-md-compliance-in-submissions-and-conduct/ Fri, 29 Aug 2025 12:55:38 +0000 https://www.clinicalstudies.in/sop-for-clino-and-clino-md-compliance-in-submissions-and-conduct/ Read More “SOP for ClinO and ClinO-MD Compliance in Submissions and Conduct” »

]]>
SOP for ClinO and ClinO-MD Compliance in Submissions and Conduct

{
“@context”: “https://schema.org”,
“@type”: “Article”,
“mainEntityOfPage”: {
“@type”: “WebPage”,
“@id”: “https://www.clinicalstudies.in/clino-and-clino-md-compliance-in-submissions-and-conduct”
},
“@id”: “https://www.clinicalstudies.in/clino-and-clino-md-compliance-in-submissions-and-conduct”,
“headline”: “SOP for ClinO and ClinO-MD Compliance in Submissions and Conduct”,
“name”: “SOP for ClinO and ClinO-MD Compliance in Submissions and Conduct”,
“description”: “Detailed SOP describing sponsor, investigator, and regulatory responsibilities for ensuring compliance with ClinO and ClinO-MD regulations for clinical trial submissions and conduct in Switzerland under Swissmedic.”,
“keywords”: “Swissmedic ClinO SOP, SOP for ClinO compliance, SOP for ClinO-MD submissions, Swiss clinical trial submission SOP, SOP for regulatory compliance Switzerland, SOP for sponsor responsibilities Swissmedic, SOP for investigator site ClinO compliance, SOP for essential documents ClinO, SOP for safety reporting ClinO Swissmedic, SOP for trial approvals Switzerland, SOP for medical device ClinO-MD SOP, SOP for Swiss ethics submissions, SOP for inspection readiness Switzerland, SOP for bilingual documentation Switzerland, SOP for Swiss retention requirements, SOP for GCP compliance Swissmedic, SOP for protocol amendments Swissmedic, SOP for SUSAR reporting Switzerland, SOP for trial governance Switzerland, SOP for regulatory submissions Swissmedic, SOP for document archiving Switzerland, SOP for trial conduct ClinO, SOP for investigator brochure submissions Switzerland, SOP for trial governance ClinO Switzerland, SOP for compliance with Swiss regulations”,
“articleSection”: “Standard Operating Procedure”,
“datePublished”: “2025-08-28”,
“dateModified”: “2025-08-28”,
“author”: { “@type”: “Organization”, “name”: “Clinicalstudies.in” },
“publisher”: {
“@type”: “Organization”,
“name”: “Clinicalstudies.in”,
“logo”: { “@type”: “ImageObject”, “url”: “https://www.clinicalstudies.in/logo.png” }
}
}

ClinO and ClinO-MD Compliance in Submissions and Conduct SOP

Department Clinical Research
SOP No. CS/SWISS-CLINO/189/2025
Supersedes N.A.
Page No. 1 of 24
Issue Date 28/08/2025
Effective Date 05/09/2025
Review Date 05/09/2027

Purpose

The purpose of this SOP is to define processes for ensuring compliance with the Swiss Ordinance on Clinical Trials in Human Research (ClinO) and the Ordinance on Clinical Trials with Medical Devices (ClinO-MD). It outlines the submission, approval, conduct, monitoring, and reporting requirements under Swissmedic, ensuring ethical and regulatory adherence.

Scope

This SOP applies to all clinical trials involving medicinal products and medical devices conducted in Switzerland under ClinO and ClinO-MD regulations. It covers sponsor obligations, investigator responsibilities, ethics committee submissions, safety reporting, amendments, and archiving of trial documents.

Responsibilities

  • Sponsor: Ensures compliance with ClinO and ClinO-MD requirements, prepares submission dossiers, and maintains oversight.
  • Regulatory Affairs (RA): Submits dossiers to Swissmedic and BASEC (ethics committee) and tracks approvals.
  • Principal Investigator (PI): Conducts trials per ClinO/ClinO-MD, maintains documentation, and ensures subject safety.
  • Clinical Project Manager (CPM): Coordinates timelines and ensures trial conduct is aligned with approvals.
  • Quality Assurance (QA): Audits trial documents and processes to ensure readiness for inspections.

Accountability

The Sponsor’s Head of Regulatory Affairs is accountable for compliance with ClinO/ClinO-MD obligations. The PI is accountable for site-level adherence and subject protection.

Procedure

1. Preparation of Submission Dossier

  1. Compile CTA dossier including protocol, Investigator’s Brochure, ICF, IMPD (for drugs), or device dossier (for medical devices).
  2. Ensure translations into German, French, or Italian as required.
  3. Maintain Submission Checklist (Annexure-1).

2. Submissions to Swissmedic and BASEC

  1. Submit dossiers electronically through Swissmedic and BASEC portals.
  2. Record submission acknowledgments in Submission Log.

3. Trial Conduct and Monitoring

  1. Conduct trial in compliance with ClinO/ClinO-MD, GCP, and local ethics requirements.
  2. Maintain Trial Master File (TMF) with all essential documents.

4. Safety Reporting

  1. Submit SUSARs to Swissmedic and BASEC within required timelines.
  2. Report annual safety updates (DSURs) to authorities.

5. Protocol Amendments

  1. Submit substantial amendments to Swissmedic and BASEC prior to implementation.
  2. Record approvals in Amendment Log (Annexure-2).

6. Archiving

  1. Archive TMF and ISF records for at least 10 years or as per ClinO retention requirements.

Abbreviations

  • ClinO: Ordinance on Clinical Trials in Human Research
  • ClinO-MD: Ordinance on Clinical Trials with Medical Devices
  • Swissmedic: Swiss Agency for Therapeutic Products
  • BASEC: Business Administration System for Ethics Committees
  • CTA: Clinical Trial Application
  • ICF: Informed Consent Form
  • IMPD: Investigational Medicinal Product Dossier
  • PI: Principal Investigator
  • RA: Regulatory Affairs
  • QA: Quality Assurance
  • CPM: Clinical Project Manager
  • TMF: Trial Master File
  • ISF: Investigator Site File

Documents

  1. Submission Checklist (Annexure-1)
  2. Amendment Log (Annexure-2)
  3. Safety Reporting Log (Annexure-3)

References

Version: 1.0

Approval

Prepared By Checked By Approved By
Name: Rajesh Kumar
Date: 20/08/2025
Signature: __________
Name: Sunita Reddy
Date: 22/08/2025
Signature: __________
Name: Dr. Meera Iyer
Date: 28/08/2025
Signature: __________

Annexures

Annexure-1: Submission Checklist

Document Included (Y/N) Reviewer Date
Protocol Y Rajesh Kumar 05/08/2025
Investigator’s Brochure Y Sunita Reddy 06/08/2025

Annexure-2: Amendment Log

Date Amendment Submitted To Status Owner
15/09/2025 Amendment 1 — Updated risk management plan Swissmedic & BASEC Under Review Neha Sharma

Annexure-3: Safety Reporting Log

Date Case ID Event Submitted To Status
12/08/2025 CH-001 Severe Anaphylaxis Swissmedic Submitted

Revision History

Revision Date Revision No. Revision Details Reason for Revision Approved By
28/08/2025 1.0 Initial SOP for ClinO and ClinO-MD compliance in submissions and conduct. New SOP created for Swissmedic regulatory compliance. Head of Clinical Research

For more SOPs visit: Pharma SOP.

]]>